Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Learn More News The Latest From Transcend Read More Press Release Transcend Therapeutics Announces Completion of Acquisition by Otsuka Pharmaceutical Read More Press Release Transcend Therapeutics Receives FDA National Priority Voucher for TSND-201 in PTSD Read More Press Release Otsuka Pharmaceutical to Acquire Transcend Therapeutics Read More Press Release IMPACT-1 Study Published in JAMA Psychiatry: Results of TSND-201 (Methylone) in Patients with Severe PTSD Learn More Our Mission Striving for a world without neuropsychiatric disease
The Big Problem: Wheres the Human Evidence
1-Methyl-4-phenylpyridinium ion (MPP + ): identification of a metabolite of MPTP, a toxin selective to the substantia nigra
Funding The research was funded by the Department of Science and Technology, Government of India, vide award number DST/INSPIRE Fellowship/2015/IF150691
If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT"
.png)
US$ 22.13
US$ 22.16
US$ 23.62
US$ 24.35
